ABSTRACT
Lumefantrine contributes significant roles in artemisinin-based combination therapy for malaria treatment but associated with a limitation of poor aqueous solubility and low permeability. This study investigated lumefantrine-2-hydroxypropyl-β-cyclodextrin complex to improve its solubility profile. A phase-solubility analysis and molecular modelling were carried out before the preparation of the complex by physical mixture, kneading, co-evaporation and freeze-drying methods. Fourier transform infrared (FT-IR) spectroscopic and powder X-ray diffractometric (PXRD) techniques were used to characterised the complex. The phase-solubility studies showed a type AL diagram with an apparent stability constant value of 243.4 M-1suggesting the formation of a soluble and stable complex. Significant improvements in aqueous solubility was achieved, notably the freeze